רפמיון 1 מ"ג

Pajjiż: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

SIROLIMUS 1.00 MG

Disponibbli minn:

NEOPHARM LTD

Kodiċi ATC:

L04AA10

Għamla farmaċewtika:

COATED TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

PFIZER IRELAND PHARMACEUTICALS

Grupp terapewtiku:

SIROLIMUS

Indikazzjonijiet terapewtiċi:

Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Data ta 'l-awtorizzazzjoni:

2009-10-01